Literature DB >> 34219782

Evaluation of platelet-rich plasma applied in the coronary band of healthy equine hooves.

Sarah Raphaela Torquato Seidel1, Anderson Fernando de Souza1, Joice Fülber1, Paulo Moreira Bogossian1, Nubia Nayara Pereira Rodrigues1, Raquel Yvonne Arantes Baccarin1.   

Abstract

Platelet-rich plasma (PRP) is a widely used hemocomponent that holds great promise in equine medicine due to its feasible production and regenerative therapy potential. Its use has been considered as a treatment for chronic laminitis, mainly in terms of its analgesic properties and because it can induce growth in affected hooves. The aim of this study was to evaluate the effect on hoof growth attributable to PRP applied in the coronary band of clinically healthy horses by comparing the responses to PRP, saline, and trimming alone. After randomization, the forelimbs of 9 horses received specific treatment at intervals of 33 days and were trimmed, measured, and radiographed at the same time. Neither hoof growth nor hoof angles were different between the treatment groups at any time point. The application of PRP in the coronary band of horses may be a safe procedure; however, it had no effect on the growth or conformation of hooves in clinically healthy horses. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Year:  2021        PMID: 34219782      PMCID: PMC8218955     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  20 in total

Review 1.  Chronic laminitis: current treatment strategies.

Authors:  Andrew Parks; Stephen E O'Grady
Journal:  Vet Clin North Am Equine Pract       Date:  2003-08       Impact factor: 1.792

2.  Platelet-rich plasma: a milieu of bioactive factors.

Authors:  Stacie G Boswell; Brian J Cole; Emily A Sundman; Vasili Karas; Lisa A Fortier
Journal:  Arthroscopy       Date:  2012-01-28       Impact factor: 4.772

3.  Evaluation of Three Methods of Platelet-Rich Plasma for Treatment of Equine Distal Limb Skin Wounds.

Authors:  Roberta Carneiro da Fontoura Pereira; Flávio Desessards De La Côrte; Karin Erica Brass; Marcos da Silva Azevedo; Miguel Gallio; Camila Cantarelli; Stefano Leite Dau; Alfredo Skrebsky Cezar; Maria Andréia Inkelmann
Journal:  J Equine Vet Sci       Date:  2017-10-14       Impact factor: 1.583

Review 4.  Platelet-rich Plasma and Other Hemocomponents in Veterinary Regenerative Medicine.

Authors:  Adolfo Maria Tambella; Stefano Martin; Andrea Cantalamessa; Evelina Serri; Anna Rita Attili
Journal:  Wounds       Date:  2018-11       Impact factor: 1.546

5.  Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis.

Authors:  S R Bailey; H S Adair; C R Reinemeyer; S J Morgan; A C Brooks; S L Longhofer; J Elliott
Journal:  Vet Immunol Immunopathol       Date:  2008-11-07       Impact factor: 2.046

Review 6.  Growth factor content in PRP and their applicability in medicine.

Authors:  A Lubkowska; B Dolegowska; G Banfi
Journal:  J Biol Regul Homeost Agents       Date:  2012 Apr-Jun       Impact factor: 1.711

7.  Comparison of platelet counting technologies in equine platelet concentrates.

Authors:  Caitlin M O'Shea; Stephen R Werre; Linda A Dahlgren
Journal:  Vet Surg       Date:  2014-10-13       Impact factor: 1.495

8.  Platelet-rich plasma peptides: key for regeneration.

Authors:  Dolores Javier Sánchez-González; Enrique Méndez-Bolaina; Nayeli Isabel Trejo-Bahena
Journal:  Int J Pept       Date:  2012-02-22

9.  Does Double Centrifugation Lead to Premature Platelet Aggregation and Decreased TGF-β1 Concentrations in Equine Platelet-Rich Plasma?

Authors:  Sarah R T Seidel; Cynthia P Vendruscolo; Juliana J Moreira; Joice Fülber; Tatiana F Ottaiano; Maria L V Oliva; Yara M Michelacci; Raquel Y A Baccarin
Journal:  Vet Sci       Date:  2019-08-21

10.  Changes in Hoof Shape During a Seven-Week Period When Horses Were Shod Versus Barefoot.

Authors:  Sara R Malone; Helen M S Davies
Journal:  Animals (Basel)       Date:  2019-11-22       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.